Related Experiment Video
Updated: Aug 7, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Step-down therapy in hypertension. Importance in long-term management
Insights
Reducing antihypertensive medication is feasible for many patients. Step-down therapy successfully decreased or eliminated drugs in most patients, with a significant reduction in side effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension management often involves multiple medications.
- Determining the minimum effective therapeutic regimen is crucial for patient care.
Purpose of the Study:
- To ascertain the minimal antihypertensive drug therapy required for sustained blood pressure control.
- To evaluate the safety and efficacy of a step-down approach in managing hypertension.
Main Methods:
- A cohort of 51 hypertensive patients with controlled diastolic pressure (<90 mm Hg for six months) underwent medication reduction or discontinuation.
- Therapeutic adjustments were monitored over 18 months.
Main Results:
- Within six months, 38 patients had one drug eliminated, and 49 had a dose decreased.
- By 12 months, 13 patients required intensified therapy; 27 had one drug eliminated, and 43 had a dose decreased.
- A significant reduction in reported side effects was observed, with 56% completely absent post-therapy adjustment.
Conclusions:
- Step-down therapy is a viable strategy for reducing antihypertensive medication in a substantial proportion of patients.
- This approach can lead to a significant decrease in medication burden and a marked improvement in the tolerability of treatment.
Abstract:
To determine the minimum amount of therapy needed to control arterial pressure, the amount of one drug was reduced, then use of one or more drugs was discontinued after the diastolic pressure had been lower than 90 mm Hg for six months in 51 hypertensive patients. By six months, one drug had been eliminated in 38 patients, and the dose of another had been decreased in 49 patients. By 12 months, stepping up therapy was necessary in 13 patients; thus, one drug therapy had been eliminated in only 27 patients, and the dose was decreased in another 43 patients. No further therapeutic changes were necessary during the next six months. Originally, 161 complaints of side effects were noted. After step-down therapy, 18% of the side effects were reported unchanged, 26% were significantly decreased, and 56% were completely absent.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Drug Therapy
Antianxiety Medications

